BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21628466)

  • 1. Bone morphogenetic protein 3 controls insulin gene expression and is down-regulated in INS-1 cells inducibly expressing a hepatocyte nuclear factor 1A-maturity-onset diabetes of the young mutation.
    Bonner C; Farrelly AM; Concannon CG; Dussmann H; Baquié M; Virard I; Wobser H; Kögel D; Wollheim CB; Rupnik M; Byrne MM; König HG; Prehn JH
    J Biol Chem; 2011 Jul; 286(29):25719-28. PubMed ID: 21628466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INS-1 cells undergoing caspase-dependent apoptosis enhance the regenerative capacity of neighboring cells.
    Bonner C; Bacon S; Concannon CG; Rizvi SR; Baquié M; Farrelly AM; Kilbride SM; Dussmann H; Ward MW; Boulanger CM; Wollheim CB; Graf R; Byrne MM; Prehn JH
    Diabetes; 2010 Nov; 59(11):2799-808. PubMed ID: 20682686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of hepatocyte nuclear factor-1A and -4A on pancreatic stone protein/regenerating protein and C-reactive protein gene expression: implications for maturity-onset diabetes of the young.
    Kyithar MP; Bonner C; Bacon S; Kilbride SM; Schmid J; Graf R; Prehn JH; Byrne MM
    J Transl Med; 2013 Jun; 11():156. PubMed ID: 23803251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of circulating microRNAs in HNF1A-MODY carriers.
    Bonner C; Nyhan KC; Bacon S; Kyithar MP; Schmid J; Concannon CG; Bray IM; Stallings RL; Prehn JH; Byrne MM
    Diabetologia; 2013 Aug; 56(8):1743-51. PubMed ID: 23674172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity Onset Diabetes of the Young (MODY) in Tunisia: Low frequencies of GCK and HNF1A mutations.
    Ben Khelifa S; Martinez R; Dandana A; Khochtali I; Ferchichi S; Castaño L
    Gene; 2018 Apr; 651():44-48. PubMed ID: 29408271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Maturity onset diabetes of the young due to
    Pavić T; Juszczak A; Pape Medvidović E; Burrows C; Šekerija M; Bennett AJ; Ćuća Knežević J; Gloyn AL; Lauc G; McCarthy MI; Gornik O; Owen KR
    Biochem Med (Zagreb); 2018 Jun; 28(2):020703. PubMed ID: 29666556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early loss of mammalian target of rapamycin complex 1 (mTORC1) signalling and reduction in cell size during dominant-negative suppression of hepatic nuclear factor 1-alpha (HNF1A) function in INS-1 insulinoma cells.
    Farrelly AM; Wobser H; Bonner C; Anguissola S; Rehm M; Concannon CG; Prehn JH; Byrne MM
    Diabetologia; 2009 Jan; 52(1):136-44. PubMed ID: 18949455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells.
    Farrelly AM; Kilbride SM; Bonner C; Prehn JH; Byrne MM
    Apoptosis; 2011 Nov; 16(11):1128-37. PubMed ID: 21874357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AMP-activated protein kinase mediates apoptosis in response to bioenergetic stress through activation of the pro-apoptotic Bcl-2 homology domain-3-only protein BMF.
    Kilbride SM; Farrelly AM; Bonner C; Ward MW; Nyhan KC; Concannon CG; Wollheim CB; Byrne MM; Prehn JH
    J Biol Chem; 2010 Nov; 285(46):36199-206. PubMed ID: 20841353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young.
    Ellard S; Colclough K
    Hum Mutat; 2006 Sep; 27(9):854-69. PubMed ID: 16917892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of HNF1A-MODY and HNF4A-MODY in Irish families: phenotypic characteristics and therapeutic implications.
    Kyithar MP; Bacon S; Pannu KK; Rizvi SR; Colclough K; Ellard S; Byrne MM
    Diabetes Metab; 2011 Dec; 37(6):512-9. PubMed ID: 21683639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha and 4 alpha in maturity-onset diabetes of the young and hyperinsulinemic hypoglycemia.
    Colclough K; Bellanne-Chantelot C; Saint-Martin C; Flanagan SE; Ellard S
    Hum Mutat; 2013 May; 34(5):669-85. PubMed ID: 23348805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HNF1α controls glucagon secretion in pancreatic α-cells through modulation of SGLT1.
    Sato Y; Rahman MM; Haneda M; Tsuyama T; Mizumoto T; Yoshizawa T; Kitamura T; Gonzalez FJ; Yamamura KI; Yamagata K
    Biochim Biophys Acta Mol Basis Dis; 2020 Nov; 1866(11):165898. PubMed ID: 32711050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of HNF-1α mutations associated with familial young-onset diabetes on target gene regulation.
    Galán M; García-Herrero CM; Azriel S; Gargallo M; Durán M; Gorgojo JJ; Andía VM; Navas MA
    Mol Med; 2011; 17(3-4):256-65. PubMed ID: 21170474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-function studies of HNF1A (MODY3) gene mutations in South Indian patients with monogenic diabetes.
    Balamurugan K; Bjørkhaug L; Mahajan S; Kanthimathi S; Njølstad PR; Srinivasan N; Mohan V; Radha V
    Clin Genet; 2016 Dec; 90(6):486-495. PubMed ID: 26853433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HNF1A-MODY Mutations in Nuclear Localization Signal Impair HNF1A-Import Receptor KPNA6 Interactions.
    Fareed FMA; Korulu S; Özbil M; Çapan ÖY
    Protein J; 2021 Aug; 40(4):512-521. PubMed ID: 33459938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of novel variants in the hepatocyte nuclear factor-1alpha gene in South Indian patients with maturity onset diabetes of young.
    Radha V; Ek J; Anuradha S; Hansen T; Pedersen O; Mohan V
    J Clin Endocrinol Metab; 2009 Jun; 94(6):1959-65. PubMed ID: 19336507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the promoter regions of disease-causing genes in maturity-onset diabetes of the young patients.
    Komazec J; Ristivojevic B; Zukic B; Zdravkovic V; Karan-Djurasevic T; Pavlovic S; Ugrin M
    Mol Biol Rep; 2020 Sep; 47(9):6759-6768. PubMed ID: 32860162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective functions of HNF1A variants on BCL2L1 transactivation and beta-cell growth.
    Sujjitjoon J; Charoensuk C; Thanyaphon T; Kooptiwut S; Thamtarana PJ; Tangjittipokin W; Chongjaroen N; Chanprasert C; Abubakar Z; Lapbenjakul S; Yenchitsomanus PT; Plengvidhya N
    Biochem Biophys Res Commun; 2020 Aug; 529(3):826-833. PubMed ID: 32684311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.